Literature DB >> 22193385

Differences in bone quality in low- and high-turnover renal osteodystrophy.

Hartmut H Malluche1, Daniel S Porter, Marie-Claude Monier-Faugere, Hanna Mawad, David Pienkowski.   

Abstract

Abnormal bone turnover is common in CKD, but its effects on bone quality remain unclear. We qualitatively screened iliac crest bone specimens from patients on dialysis to identify those patients with low (n=18) or high (n=17) bone turnover. In addition, we obtained control bone specimens from 12 healthy volunteers with normal kidney function. In the patient and control specimens, Fourier transform infrared spectroscopy and nanoindentation quantified the material and mechanical properties of the specimens, and we used bone histomorphometry to assess parameters of bone microstructure and bone formation and resorption. Compared with high or normal turnover, bone with low turnover had microstructural abnormalities such as lower cancellous bone volume and reduced trabecular thickness. Compared with normal or low turnover, bone with high turnover had material and nanomechanical abnormalities such as reduced mineral to matrix ratio and lower stiffness. These data suggest that turnover-related alterations in bone quality may contribute to the diminished mechanical competence of bone in CKD, albeit through different mechanisms. Therapies tailored specifically to low- or high-turnover bone may treat renal osteodystrophy more effectively.

Entities:  

Mesh:

Year:  2011        PMID: 22193385      PMCID: PMC3294305          DOI: 10.1681/ASN.2010121253

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  43 in total

1.  Performance of μMRI-Based virtual bone biopsy for structural and mechanical analysis at the distal tibia at 7T field strength.

Authors:  Yusuf A Bhagat; Chamith S Rajapakse; Jeremy F Magland; James H Love; Alexander C Wright; Michael J Wald; Hee Kwon Song; Felix W Wehrli
Journal:  J Magn Reson Imaging       Date:  2011-02       Impact factor: 4.813

Review 2.  Bone quality: understanding what matters.

Authors:  D B Burr
Journal:  J Musculoskelet Neuronal Interact       Date:  2004-06       Impact factor: 2.041

3.  FTIR microspectroscopic analysis of normal human cortical and trabecular bone.

Authors:  E P Paschalis; F Betts; E DiCarlo; R Mendelsohn; A L Boskey
Journal:  Calcif Tissue Int       Date:  1997-12       Impact factor: 4.333

4.  Mechanical and morphological variation of the human lumbar vertebral cortical and trabecular bone.

Authors:  M E Roy; J Y Rho; T Y Tsui; N D Evans; G M Pharr
Journal:  J Biomed Mater Res       Date:  1999-02

5.  Risk factors for hip fracture among patients with end-stage renal disease.

Authors:  C O Stehman-Breen; D J Sherrard; A M Alem; D L Gillen; S R Heckbert; C S Wong; A Ball; N S Weiss
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

6.  Infrared spectroscopy indicates altered bone turnover and remodeling activity in renal osteodystrophy.

Authors:  Hanna Isaksson; Mikael J Turunen; Lassi Rieppo; Simo Saarakkala; Inari S Tamminen; Jarno Rieppo; Heikki Kröger; Jukka S Jurvelin
Journal:  J Bone Miner Res       Date:  2010-06       Impact factor: 6.741

7.  Increased risk of hip fracture among patients with end-stage renal disease.

Authors:  A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

8.  Relationship between moderate to severe kidney disease and hip fracture in the United States.

Authors:  Thomas L Nickolas; Donald J McMahon; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2006-09-27       Impact factor: 10.121

9.  Elastic properties of human cortical and trabecular lamellar bone measured by nanoindentation.

Authors:  J Y Rho; T Y Tsui; G M Pharr
Journal:  Biomaterials       Date:  1997-10       Impact factor: 12.479

10.  Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy.

Authors:  A H M Ng; G Hercz; R Kandel; M D Grynpas
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

View more
  52 in total

1.  Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality.

Authors:  Astrid Starke; Alf Corsenca; Thomas Kohler; Johannes Knubben; Marius Kraenzlin; Daniel Uebelhart; Rudolf P Wüthrich; Brigitte von Rechenberg; Ralph Müller; Patrice M Ambühl
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 8.237

2.  Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture.

Authors:  Jan M Hughes-Austin; Ronit Katz; Richard D Semba; Stephen B Kritchevsky; Douglas C Bauer; Mark J Sarnak; Charles Ginsberg; Michael G Shlipak; Florence Lima; Hartmut H Malluche; Joachim H Ix
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

3.  Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease.

Authors:  K Žamboch; K Krejčí; J Škarda; M Tichý; I Überall; P Skýpalová; K Langová; D Stejskal; M Švesták; J Zahálková; V Ščudla; J Zadražil
Journal:  Int Urol Nephrol       Date:  2015-05-01       Impact factor: 2.370

Review 4.  Biomarkers Predicting Bone Turnover in the Setting of CKD.

Authors:  Pieter Evenepoel; Etienne Cavalier; Patrick C D'Haese
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 5.  Vibrational spectroscopic techniques to assess bone quality.

Authors:  E P Paschalis; S Gamsjaeger; K Klaushofer
Journal:  Osteoporos Int       Date:  2017-04-05       Impact factor: 4.507

Review 6.  Bone composition: relationship to bone fragility and antiosteoporotic drug effects.

Authors:  Adele L Boskey
Journal:  Bonekey Rep       Date:  2013-12-04

7.  Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing.

Authors:  Elizabeth A Swallow; Mohammad W Aref; Corinne E Metzger; Spencer Sacks; Demi R Lehmkuhler; Neal Chen; Max A Hammond; Paul R Territo; Thomas L Nickolas; Sharon M Moe; Matthew R Allen
Journal:  Bone       Date:  2019-07-09       Impact factor: 4.398

8.  Young's modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years.

Authors:  D Pienkowski; C L Wood; H H Malluche
Journal:  Osteoporos Int       Date:  2018-11-28       Impact factor: 4.507

9.  Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.

Authors:  Daniel Cejka; Diego Parada-Rodriguez; Stefanie Pichler; Rodrig Marculescu; Ina Kramer; Michaela Kneissel; Thomas Gross; Andreas Reisinger; Dieter Pahr; Marie-Claude Monier-Faugere; Martin Haas; Hartmut H Malluche
Journal:  Kidney Int       Date:  2016-08-12       Impact factor: 10.612

10.  Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.

Authors:  J Ward; C Wood; K Rouch; D Pienkowski; H H Malluche
Journal:  Osteoporos Int       Date:  2016-07-22       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.